About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Managing a Gastrocolocutaneous Fistula with Delayed Presentation after PEG Placement without Surgery
Kaveh Najafi1, Helen Markowski1, DJ Green1, Frank Bauer1, Bruce Davis1, Karen Lewandowski RN2, Shashvat M Desai2, John P Kepros1
1Department of Trauma, Acute Care Surgery and Surgical Critical Care, HonorHealth Scottsdale Osborn, Scottsdale, AZ; 2Honor Health Research Institute, Honor Health Scottsdale Osborn, Scottsdale, AZ.
Corresponding Author:
Dr Kaveh Najafi
Email: knajafi@honorhealth.com
Received: 14-APR-2022 Accepted: 18-JAN-2023 Published Online: 25-JAN-2023
DOI: http://dx.doi.org/10.17659/01.2023.0003
Abstract
Background: This case report describes the successful non-surgical management of a gastrocolocutaneous fistula that developed following percutaneous endoscopic gastrostomy (PEG) placement. Case Report: The patient presented several months after the procedure with abdominal pain and discharge from the PEG site. Imaging revealed a fistula between the stomach and colon, which was managed conservatively with PEG site care, bowel rest, and antibiotics. The patient's symptoms gradually improved over several weeks, and follow-up imaging showed resolution of the fistula. Conclusion: This case demonstrates that non-operative management can be a viable option for select patients with delayed gastrocolocutaneous fistulas after PEG placement.
Keywords : Abdominal Pain, Endoscope, Gastrostomy, Postoperative Complication, Ventilator.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024